Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 14 (2) , 238-243
Abstract
No abstract availableKeywords
Funding Information
- King Abdulaziz City for Science and Technology
This publication has 42 references indexed in Scilit:
- RNAi: antiviral therapy against dengue virusAsian Pacific Journal of Tropical Biomedicine, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- RNAi in the regulation of mammalian viral infectionsBMC Biology, 2012
- siRNA Design Software for a Target Gene-Specific RNA InterferenceFrontiers in Genetics, 2012
- MysiRNA-Designer: A Workflow for Efficient siRNA DesignPLOS ONE, 2011
- Inhibition of Dengue Virus Infections in Cell Cultures and in AG129 Mice by a Small Interfering RNA Targeting a Highly Conserved SequenceJournal of Virology, 2011
- Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR proteinNucleic Acids Research, 2010
- siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effectBMC Bioinformatics, 2009
- The role of RNAi and microRNAs in animal virus replication and antiviral immunityGenes & Development, 2009
- Position-specific chemical modification of siRNAs reduces “off-target” transcript silencingRNA, 2006